ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Price Passes Above Fifty Day Moving Average – What’s Next?

ChronoScale Corporation Common Stock (NASDAQ:CHRN)’s stock price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $12.34 and traded as high as $18.91. ChronoScale Corporation Common Stock shares last traded at $18.36, with a volume of 177,507 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a research note on Friday, March 27th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Reduce” and an average price target of $6.00.

ChronoScale Corporation Common Stock Stock Up 0.4%

The business’s fifty day moving average price is $12.34 and its 200 day moving average price is $9.38. The company has a quick ratio of 1.03, a current ratio of 1.55 and a debt-to-equity ratio of 0.25. The firm has a market capitalization of $65.42 million, a PE ratio of -3.41 and a beta of 0.86.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last announced its earnings results on Tuesday, April 28th. The company reported ($2.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($2.01). The business had revenue of $2.14 million during the quarter, compared to analysts’ expectations of $4.29 million. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. On average, equities research analysts forecast that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current fiscal year.

Institutional Trading of ChronoScale Corporation Common Stock

Several large investors have recently modified their holdings of CHRN. Consolidated Portfolio Review Corp acquired a new stake in shares of ChronoScale Corporation Common Stock in the third quarter valued at approximately $333,000. Shay Capital LLC purchased a new position in shares of ChronoScale Corporation Common Stock during the third quarter valued at approximately $67,000. Virtu Financial LLC purchased a new position in shares of ChronoScale Corporation Common Stock during the third quarter valued at approximately $57,000. Citadel Advisors LLC purchased a new position in shares of ChronoScale Corporation Common Stock during the third quarter valued at approximately $198,000. Finally, Geode Capital Management LLC lifted its stake in shares of ChronoScale Corporation Common Stock by 68.9% during the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock valued at $218,000 after buying an additional 10,281 shares during the period. 6.42% of the stock is currently owned by institutional investors and hedge funds.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.